<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia

<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia

Broad-spectrum antibiotics administered to patients with severe COVID-19 pneumonia pose a risk of infection caused by <i>Clostridioides difficile</i>. This risk is reduced mainly by strict hygiene measures and early de-escalation of antibiotic therapy. Recently, oral vancomycin prophylax...

Full description

Bibliographic Details
Main Authors: Kateřina Bogdanová, Lenka Doubravská, Iva Vágnerová, Kristýna Hricová, Vendula Pudová, Magdaléna Röderová, Jan Papajk, Radovan Uvízl, Kateřina Langová, Milan Kolář
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Life
Subjects:
COVID-19
<i>Clostridioides difficile</i>
oral vancomycin prophylaxis
vancomycin-resistant enterococci
molecular typing of VRE
ICU
Online Access:https://www.mdpi.com/2075-1729/11/11/1127

Internet

https://www.mdpi.com/2075-1729/11/11/1127

Similar Items